Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: M. Ramle who wrote (1189)	6/15/2000 4:58:00 PM
From: Biomaven	Read Replies (2) \| Respond to of 52153

Here's a preliminary list of the Russell 2000/3000 index biotech adds. As you can see, practically every serious biotech known to man that wasn't already on it. (I count around 75 biotech additions. Note that I probably missed a few other biotechs or included some spurious ones) My guess is that overall this should produce some nice support over the next month or so for the biotech third tier. Two years ago (in the biotech apathy era), you would have done well buying the biotech "adds" and shorting the "deletes." I suspect that with the higher volumes we now see in most biotechs the impact will be lower this year, but we might yet see some noticeable strength in the lower-volume issues. ATIS ALXN ALLP AMLN AGEN APHT ARDM ARIA ABSC AVAN AVGN BCRX BMRN BPUR BSTE CALP CDIC CEGE CTIC CLTX CNCT CBMI CRY CBST CRGN CVTX DMED DIGE DUSA EMIS ENDO EXEL GLGC DNA GENE GNSL GNTA GZTC GERN HYSQ ILXO IMNR IMGN IMMU ITMN IBPI KOSP MATK MATX MAXM MAXY MEDX MOGN MRVT MYGN NABI NGEN NERX NBIX NEXL NOVN NPSP ORCH OSIP PCOP PHGN RZYM SQNM TNOX TXB TTP TRMS TLRK VASO VXGN Peter